This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Cyclacel Pharmaceuticals Inc.
CYCC : NASDAQ : Health Care

$3.28 | %
Today's Range: 3.12 - 3.31
Avg. Daily Volume: 174,400
04/17/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
CYCC CYCLACEL PHARMACEUTICALS 3.57 84.08 n/m 1.08 1471.01
OGEN ORAGENICS INC 2.63 95.02 n/m 1.03 -22.53
CVM CEL-SCI CORP 1.56 87.34 n/m 0.26 -2.65
KBIO KALOBIOS PHARMACEUTICALS INC 2.39 78.82 n/m 0.04 -49.43
PIP PHARMATHENE INC 1.44 77.13 n/m 17.91 -28.85
AVEO AVEO PHARMACEUTICALS INC 1.45 75.10 n/m 1.29 -93.30
STEM STEMCELLS INC 1.27 70.38 n/m 1.20 -12.07
LPTN LPATH INC 4.57 68.45 n/m 6.87 -21.91
TROV TROVAGENE INC 5.58 122.79 n/m 0.38 16.82
ARQL ARQULE INC 1.88 118.18 n/m 15.91 -56.30
VICL VICAL INC 1.18 102.44 n/m 7.72 -55.95
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CYCC Ind Avg S&P 500
n/m 43.67 18.29
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs